Evaluation of the performance of a new OptiScanner™ 5000 system for an intermittent glucose monitoring.


BACKGROUND Mid-infrared spectral technology has shown a high degree of promise in detecting glucose in plasma. OptiScan Biomedical has developed a glucose monitor based on mid-infrared spectroscopy that withdraws blood samples and measures plasma glucose. The objective of this study was to evaluate the accuracy and performance of the OptiScanner™ 5000… (More)
DOI: 10.1016/j.cca.2014.09.008


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics